Lv, H., He, J., Zhuang, X., Jiang, S., Man, X., Wang, R., Yang, R., Zeng, X., Qian, H., Shi, Y. (2025). FGF11–HIF-1α glycolytic epigenetic axis drives AML progression and chemoresistance via metabolic reprogramming. Blood. https://doi.org/10.1182/blood-2025-3185